Pharmacy Podcast Network

Empowering People to Live Healthier Lives, a special podcast with Dr. Richard Ashworth | The Public Health Pharmacist

Empowering People to Live Healthier Lives, a special podcast with Dr. Richard Ashworth
Pharmacists, Physcians, and people commited to better health for our nation are working closer than ever before. Dr. Richard Ashworth believes we can do more. Interesting insights on how the healthy aging sector will evolve post-pandemic – including concerns on reported increased levels of stress in seniors and the need to more actively address social determinants of health. Dr. Ashworth and Dr. Madison also talk about navigating the shift to virtual engagement and the opportunities and challenges healthcare organizations will face once the nation fully reopens from COVID-19. 
Our guest:
Dr. Richard Ashworth, PharmD joined Tivity Health as President and CEO, and as a member of the Board of Directors, in June 2020. Previously, Ashworth facilitated the growth of Walgreens for nearly 30 years, transforming the company into a global leader in pharmacy and health and wellness. He started at Walgreens as a store clerk in 1992, and most recently led as President, responsible for developing the strategies and plans for all Walgreens operations including leadership, development and management of the business.
Ashworth has spent his career focused on improving the health and well-being of others, with a passion for making a difference in the lives of customers and members. His experience includes navigating a rapidly changing healthcare landscape while serving a portfolio of large customers and individual consumers in the intensely competitive retail realm. Ashworth is an influential voice in public health policy and the future of healthcare and has shared his views at the White House and on Capitol Hill. He also served on the NACDS board for the last four years, formerly as Chairman.
Ashworth earned a Doctor of Pharmacy degree (PharmD) and a master's degree in business administration.
Our host:
Dr. Christina Madison, PharmD is the Founder and CEO of The Public Health Pharmacist™, PLLC a public health consulting firm. She is a clinical pharmacist specializing in public health with a focus on infectious communicable diseases. As a past President of the Nevada Public Health Association, she has been asked to share her clinical public health and infectious disease expertise with Local, State, and International Media outlets and NGO’s.
Dr. Madison has been featured in over 200+ on-air TV appearances since January 2020 related to the pandemic and public health. She has an intimate knowledge of the impact public health messaging, policy, and legislation can have on communities.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Enhance Care Decision Making with Evidence & AI | Pharmacy Talk with IBM Watson Heatlh

Special guests:
Alan Ehrlich, Executive Editor at DynaMed and an Associate Professor in Family Medicine at the University of Massachusetts Medical School in Worcester
Bio: Alan Ehrlich, MD, FAAFP is the Executive Editor at DynaMed and an Associate Professor in Family Medicine at the University of Massachusetts Medical School in Worcester. He is board certified from the American Board of Family Medicine and a Fellow of the American Academy of Family Physicians. Alan graduated from Rutgers New Jersey Medical School in 1984 and completed his residency at the University of
Massachusetts Medical Center in 1987. He is involved in the teaching of Evidence-Based Medicine to third year medical students and writes the Evidence-Based Medicine column for Clinical Advisor magazine.
 Eileen Yoshida, Deputy Editor of Medication and Clinical Informatics, EBSCO Health
Bio: Eileen Yoshida is the Deputy Editor of Medication and Clinical Informatics at EBSCO Health. In this role, she leads the medication and clinical informatics strategies for the organization. Eileen brings over 25 years of experience in the healthcare industry, most recently leading the Clinical Knowledge Management and Decision Support team at Partners HealthCare. Previously, she served with Capgemini as an EHR implementation strategist and with the University of Chicago Hospitals in a special project’s role. Eileen has extensive experience in clinical informatics, EHR implementation, healthcare          consulting and clinical pharmacy and is a published author and speaker on clinical decision support. She holds a degree in Pharmacy from the University of Toronto and a master’s in business administration from the Kellogg School of Management at Northwestern University.
 Research:
Report from HIMSS19: Novel Techniques to Combat the Opioid Misuse Epidemic
Courtney Holmes, RN, Executive Clinical Consultant, IBM Watson Health
Bio: Courtney Holmes is a Clinical Program Director supporting IBM’s Micromedex solution suite, as well as an Executive Clinical Consultant with Watson Health. Courtney focuses on providing clinical leadership in the sales and development of cognitive solutions and engagement with key stakeholders to support meaningful use of Watson Health solutions. She provides subject matter expertise for the Healthcare. Provider Segment. This includes providing strategic and clinical expertise to ensure high value development/improvements and intuitive, seamless clinical workflow design. Courtney collaborates among global product offerings teams to ensure clinically relevant approaches to client engagements, and leads Watson Health solution sales activities through client briefings, demonstration of solutions, workshops and other formats as needed. 
Ms. Holmes joined IBM in 2018 and brings 17 years of extensive oncology nursing experience to the team. Her experience ranges from direct clinical care at some of the top hospitals in the country, to developing the nurse educator program for a large pharmaceutical company and leading a team of nurses in her region. Courtney spent time building strong customer relationships with key nursing organizations, targeted accounts, and other identified key customers. She also focused on providing clinical expertise and support to sales to optimize overall customer experience, as well as helping facilities achieve better patient outcomes by improving overall quality of care and providing insight on best practices.
Blog post: https://www.ibm.com/blogs/watson-health/how-ai-infused-clinical-decision-support-may-change-medicine/
Learn more about your ad choices. Visit megaphone.fm/adchoices

Risk-based Care Can Drive Better Patient Adherence

Participants and Roles:         Sheila Arquette, President & CEO, NASP, Host/Interviewer                           
Purpose: Discuss how implementing risk-based care benefits patients and can improve their adherence rates
Ashleigh Burdette, MSN, RN, is the Sr. Director of Clinical Innovation with Biologics by McKesson. Ashleigh has been a Registered Nurse for nearly 15 years and holds a Master of Science in Nursing with a specialization in leadership and administration. She began her nursing career as an oncology nurse working in both bone marrow transplant and an outpatient clinic. In 2015, she joined Optum/United Health Group to focus on oncology patient support, utilization review, and clinical case management. In 2017, she joined Cardinal Health’s hub business and had the opportunity to lead both clinical operations and account management. Ashleigh joined Biologics by McKesson in 2020 to lead cross-functional collaboration to create customized patient management solutions that support the holistic needs of patients.
·            What is risked-based care, and how does it differ from “standardized care”?
·            What’s the methodology behind risked-based care?
·            Is the nurse-patient connection important? Why or why not?
·            What are some outcomes you’ve seen with this type of personalized level of care and support?
·            If someone wanted to implement this type of tailored support in their care setting, what are some of the essential components to keep in mind?
Contact the NASP: https://naspnet.org/about
Learn more about your ad choices. Visit megaphone.fm/adchoices

phactMI: Where Pharmacists Go for Medical Information

Where Pharmacists Go for Medical Information
Due to the advancement of technology, healthcare professionals have access to a wealth of medical information in just a few strokes of their keyboard. Thinking of the quantity of resources available brings up the question, what sources of information are actually being used to inform treatment decisions?
Join us in this episode where Patrick Reilly, PA, CEO phactMI and guest speakers John Jones, MBA, Director of Technology phactMI and Evelyn Hermes-DeSantis, PharmD, BCPS, Director, Research and Publications, phactMI/ Professor Emerita, Rutgers, The State University of New Jersey discuss the most common sources of medical information and the role of manufacturers in providing scientifically accurate information.
This is the second episode in a series of three podcasts. If you have not listened to our first episode, check it out with the link below:
●           phactMI: Collaborate, Elevate, Enhance Patient Care: https://pharmacypodcast.com/2021/12/11/phactmi-podcast-series/
 
Learn more about phactMI at www.phactMI.org/about/
Follow phactMI on LinkedIn, Facebook, and Twitter
Learn more about your ad choices. Visit megaphone.fm/adchoices

Strategies for Pharmacist Involvement in Adverse Effect Management | PTCE Pharmacy Connect

Educational Objectives
·            Recognize best practices for managing adverse effects associated with immune checkpoint inhibitor (ICI)-targeted therapy combinations
 
Faculty:
Jacob K. Kettle, PharmD, BCOP
Pharmacy Manager
Ellis Fischel Cancer Center
Department of Pharmacy
University of Missouri Health Care
Columbia, Missouri
 
Faculty, has the following financial relationships with commercial interests to disclose:
Jacob Kettle, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose:
Speakers Bureau: Genentech, Merck, Amgen, Lilly, DSI
Consultant: Pfizer, Lilly
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hours (0.075 CEU) under the ACPE universal activity number 0290-0000-21-438-H01-P. The activity is available for CE credit through December 17, 2022.
This activity is supported by educational grants from Eisai Inc and Exelixis, Inc.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Establishing the Role of Targeted Therapies in Cancer Care | PTCE Pharmacy Connect

Educational Objectives
·             Describe the role of immune checkpoint inhibitor (ICI)-targeted therapy combinations across malignancies
·             Recall knowledge of ICI-targeted therapy combinations to treatment selection in patients with cancer
 
Faculty:
Jacob K. Kettle, PharmD, BCOP
Pharmacy Manager
Ellis Fischel Cancer Center
Department of Pharmacy
University of Missouri Health Care
Columbia, Missouri
Faculty, has the following financial relationships with commercial interests to disclose:
Jacob Kettle, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose:
Speakers Bureau: Genentech, Merck, Amgen, Lilly, DSI
Consultant: Pfizer, Lilly
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-21-437-H01-P. The activity is available for CE credit through December 17, 2022.
This activity is supported by educational grants from Eisai Inc and Exelixis, Inc.
Learn more about your ad choices. Visit megaphone.fm/adchoices

First Steps to Compounding Technology | The Future of Pharmacy

Introduction
As the safety of compounding practices comes under renewed scrutiny from authoritative bodies, more attention is being paid to assistive and robotic technologies. Learn how a stepped approach to adopting compounding technology can lead to safer, more efficient, and cost effective compounding operations.
Participants
Host:
Ken Perez, Vice President, Healthcare Policy and Government Affairs, Omnicell, Inc.
Guest Expert:
Kevin N. Hansen, PharmD, MS, BCPS, BCSCP, Assistant Director of Pharmacy, Moses H. Cone Memorial Hospital
Learn more about your ad choices. Visit megaphone.fm/adchoices

Red Flags in the Pharmacy Law Jungle | PAIN POD

On this episode of the PAIN POD, Mark Pain Guy Garofoli will chat with Dr. David Brushwood, a world-renowned pharmacy law expert, about all things pain management, controlled substances, drug diversion, and pharmacy law. You may be sitting down listening, but it turns out you’ll only be using the edge of the seat! Corresponding legal responsibility, check. Professional conversations between prescribers and dispensers alike, check. DEA Red Flags, check. An attempted prescription from a zoo, check, wait, what? Yes, check. You name it, if it’s pharmacy law and pain management related, it’s discussed, right here, right now, on the Pain Pod. Come one, come all, to the Pain Pod!!!
DEA Red Flags Info
Prescribers
Cash only patients and/or no acceptance of worker’s compensation or insurance
Prescribing of the same combination of highly-abused medications
Prescribing the same (high) quantities of pain drugs to most/every patient
High number of prescriptions issued per day
Geographically out-of-area patient population
Dispensers
High percentage controlled to non-controlled medications
High volumes of controlled substances generally
Same Medication(s)/Quantities prescribed by the same prescriber for many patients
Large geographical distances between pharmacy, prescriber(s), and patient
Multiple patients with the same last name or address
Sequential prescription #s for highly diverted drugs from the same prescriber
Patients receiving controlled substances from multiple prescribers
Patients seeking early prescription refills paying out-of-pocket
NABP ”Red Flags” Video
https://nabp.pharmacy/initiatives/awarxe/pharmacist-resources/
Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharmacy Insiders with Bob Graul

Bob Graul is a consultant providing Business Development Services for First Financial Bank’s Professional Services Division and has Graul Consulting – Small Business Consulting. Mr. Graul hosts Pharmacy Insiders on the Pharmacy Podcast Network.
Mr. Graul was Managing Director for the Professional Services Division of First Financial Bank which closed $50M in SBA loans annually. As National Vice President – RxOwnership for McKesson Corp from 2010 to 2015 Mr. Graul developed and launched RxOwnership and built it into a $1 billion program. Mr. Graul was President and CEO of Rancho Santa Fe Health Mart Pharmacy from 1985 to 2008 guiding it from $700K to $6M annually.
He also served as CFO for OBJ, Inc. Graul was a consultant for retail pharmacies and McKesson Corp with responsibility for the RxOwnership program from 2008 to 2010. Additionally, he has served on several Boards and held voluntary consulting positions within the pharmaceutical industry. He has broad experience in the banking, retail drug, ownership transfer and managed care industries. Graul received the Outstanding Alumni Award from National University in 1997. He was named Pharmacist of the Year in 2005 by the San Diego County Pharmacist Association.
Graul was awarded the Innovative Pharmacist of the year in February 2007 by the California Pharmacists Association. He was appointed to the California State Board of Pharmacy by Governor Schwarzenegger in February of 2007 and served for one term on the Board.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Waldenström Macroglobulinemia and Treatment Advancements with the Use of BTK Inhibitors | PTCE Pharmacy Connect

Pharmacy Times Continuing Education™ (PTCE) provides industry-leading pharmacy CE to retail, oncology, managed care, specialty, and health-system pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education.
Podcast 1: Waldenström Macroglobulinemia and Treatment Advancements with the Use of BTK Inhibitors
Educational Objectives
·             Outline the pathophysiology of Waldenström macroglobulinemia (WM) and its connection to use of new and emerging drug therapies
·             Review clinical guidelines and treatment selection in patients with WM
Faculty: Victoria Nachar, PharmD, BCOP
Clinical Pharmacist Specialist, Ambulatory Hematology Oncology
University of Michigan Rogel Cancer Center
Clinical Assistant Professor
University of Michigan College of Pharmacy
Ann Arbor, Michigan
 
Faculty has no financial relationships with commercial interests to disclose.
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-21-441-H01-P. The activity is available for CE credit through June 13, 2022. 
This activity is supported by educational grants from Pharmacyclics LLC., an AbbVie Company and Janssen Biotech, Inc; and BeiGene, Ltd.
Learn more about your ad choices. Visit megaphone.fm/adchoices

The Antitrust Episode | The PUTTcast

Listen in as host Monique Whitney speaks with special guests Dr. Benjamin Jolley and Deborah Keaveny about the vertical integration of healthcare, how it applies to antitrust, and possible steps state and federal governments can take to begin to combat the issue for pharmacies and their patients.
Host: 
Monique Whitney, PUTT Executive Director
Special Guests: 
Dr. Benjamin Jolley, PharmD
Pharmacist, Pharmacy Consultant, Blogger 
Deborah Keaveny, RPh
Pharmacist, Pharmacy Owner, PUTT Board Member
Learn more about your ad choices. Visit megaphone.fm/adchoices

The Great Road Trip Recap with Bruce Kneeland

Pharmacy pioneer Bruce Kneeland selects 4 road trip pharmacies
The trip, dubbed “Four Savvy Southern Pharmacies,” will include on-site visits and interviews with the owners of pharmacies in Texas, Arkansas, Tennessee and South Carolina.
Summary written by Sandra Levy
Independent pharmacy veteran Bruce Kneeland is once again hitting the open road on an extensive pharmacy road trip. This year's trip, dubbed “Four Savvy Southern Pharmacies,” will include on-site visits and interviews with the owners of pharmacies in four southern states: Texas, Arkansas, Tennessee and South Carolina. 
Liberty Software, is sponsoring the trip. 
[Read more: Pharmacy pioneer Bruce Kneeland selects 8 road trip pharmacies]
The key takeaway will be the production and distribution of a white paper that Kneeland will produce. The document will outline, in a step-by-step manner, the management tools and marketing techniques the four pharmacies use to successfully implement one or more of the enhanced care services their pharmacies provide.   
Kneeland will look at how these four pharmacies chose a specific enhanced care service to provide and how they got their staff to buy into providing the new service. He also will look for ways the pharmacies use features in their Liberty Software system to support these new services.
One of Liberty’s newest features is an appointment scheduler with features that help them manage their immunization program, interact with state immunization registries, automate billing procedures and auto-populate eCare plans. 
[Read more: CPESN USA taps Bruce Kneeland to support local networks]
The pharmacies Kneeland will visit provide a cross-section of independent pharmacies. One is in a major metropolitan area, another in a suburban location and two are in rural towns. Two are clinically focused and the others have more traditional front-ends. One even has an old fashion soda fountain.   
The four pharmacies to be visited are Flower Mound Pharmacy in Flower Mound, Texas; Caldwell Pharmacy in Wynne, Ark.; Kirby Whitten Pharmacy in Bartlett, Tenn.; and Roche Pharmacy in Whitmire, S.C. 
Kneeland noted that the white paper will be designed to provide pharmacy owners with a road map that will outline specific steps pharmacy owners can take to replicate the success of the four pharmacies he visits on the trip. When completed, the white paper will be made available, free of charge, to any pharmacy owner requesting it from Liberty Software
Learn more about your ad choices. Visit megaphone.fm/adchoices

phactMI: Collaborate, Elevate, Enhance Patient Care

phactMI, a 501 (c)(6) corporation, is a collaboration of Medical Information leaders from the pharmaceutical industry. These Medical Information professionals provide accurate and unbiased clinical data on their products that facilitates the safe and effective use of medicines. How and why was phactMI created?
Join us in this episode as Evelyn Hermes-DeSantis, PharmD, BCPS, Director, Research and Publications, phactMI/ Professor Emerita, Rutgers, The State University of New Jersey and guest speakers Patrick Reilly, PA, CEO, phactMI and Mary Sendi, North America Medical Information Regional Lead Pfizer/ President phactMI discuss medical information, the role of manufacturers in providing scientifically accurate information, and the genesis of phactMI.
Learn more about phactMI at www.phactMI.org/about/
Follow phactMI on LinkedIn, Facebook, and Twitter
References:
phactMI. About phactMI. www.phactMI.org/about. Accessed November 10, 2021.
Hermes-DeSantis ER, Johnson RM, Redlich A, et al. Proposed best practice guidelines for scientific response documents: a consensus statement from phactMI. Ther Innov Regul Sci. 2020;54:1303-11.
Rai R, Hermes-DeSantis ER, phactMI. Healthcare professional’s opinions on an endorsement tool for scientific response documents developed by pharmaceutical companies. phactMI Internal Data. Presented at the American Society of Health-System Pharmacists Midyear Clinical Meeting. 2019.
phactMI. Code of practice. www.phactMI.org/code-of-practice. Accessed November 10, 2021.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Gender Affirming Care for the 21st Century – Providing Quality Care to the Underserved with Dr. John Brosious | The Public Health Pharmacist

What does public health mean to you?
Access to healthcare for all walks of life
Bio 
Dr John Brosious is the founder of the gender surgery program at UNLV, and co-founder of NGAHP. After graduating from Indiana University School of Medicine, he completed his plastic surgery residency at the University of Nevada. His passion in gender affirming care began years ago while in practice in Pittsburgh, Pennsylvania. After returning to Nevada in 2016, he quickly realized the need to streamline gender-affirming healthcare in Nevada. Working with the gender expansive community is currently the focus of his practice, in addition to complex reconstruction for trauma, burn, and cancer patients. His hobbies include fitness, traveling, and tattoos.
Link: https://www.unlv.edu/people/john-brosious
Learn more about your ad choices. Visit megaphone.fm/adchoices

Medical Affairs Compliance | DarshanTalks

In this episode of DarshanTalks Podcast where host Darshan Kulkarni Pharm.D, MS, Esq. welcomes guest Michael A. Swit, Esq. to discuss Medical Affairs Compliance. Michael A. Swit is a long-time FDA regulatory Attorney and Chief Regulatory Counsel at Varian Medical Systems. He has taught and written on an array of subjects relating to FDA regulation and related commercial activities, including directing courses on FDA regulation of drug/device advertising and on generic drug approvals. A former member of the Food & Drug Law Journal Editorial Board, Mr. Swit has spoken frequently at conferences sponsored by such organizations as RAPS, FDLI, and DIA. Swit is a highly experienced food & drug law attorney who has addressed critical FDA legal issues since 1984. His vast experience includes serving as general counsel and secretary of Par Pharmaceutical, a prominent generic drug company, and, thus, he brings a commercial perspective to his work. His private practice has included stints in the FDA Law Practice Groups in the San Diego offices of both Duane Morris and Heller Ehrman, and at McKenna & Cuneo (now Dentons), in the firm's D.C. and San Diego offices. He also served for seven years as Vice President at The Weinberg Group, a premier FDA regulatory consulting firm, and as the CEO of FDAnews.com, a premier publisher of FDA newsletters and other information products.
In the initial part of the podcast, he described how to do the Varian Company functions and its role in medical affairs. At Varian, he spearheads the resolution of all legal issues impacting the regulatory, quality, and clinical challenges of the world's leading developer of radiation treatment technologies used to treat cancer and other conditions, including overseeing the firm's promotional review process. The company's aim is 'creating a world without the fear of cancer'. He mentioned every company makes mistakes or sometimes customers think that the company has done something wrong and every sphere will have a problem that is unavoidable but how to respond and the key element to tackle those circumstances that determines everything. He works in the compliance department resolving disputes and problems. The mid-segment was about the work processes and balance, then he was asked about the SOPs in medical affairs i.e. standard operating procedures for clinical practice, he had prime approaches for the same - policies, SOPs, granular work construction, and it ought to be automation. He also mentioned mnemonic words that are important in this sphere. The conversation also included The Chicago Tylenol scandal ( these were a series of poisoning deaths resulting from drug tampering in the Chicago metropolitan area in 1982) concerning crisis management and how one can do a right recall. Lastly, they touched upon the influencer marketing aspect.
Connect with Michael A. Swit:
https://www.linkedin.com/in/michaelswit/
Connect with us:
Website: http://www.darshantalks.com
Law Firm: http://www.kulkarnilawfirm.com
Twitter: https://twitter.com/darshantalks
----
Disclaimers:
1. This discussion is merely an oral discussion and should not be relied upon solely on its own to support any conclusion of law or fact.
2. The discussion does not and should not reflect any individual products status as safe, efficacious, adulterated, or misbranded or meeting or not meeting expectations at a local, state, federal, or international agency or organization.
3. The discussion should not be construed to be complete advice that is right for you and may not necessarily represent a specific product.
4. This discussion is provided for general educational purposes and should not be construed as legal advice, regulatory advice, or medical advice.
5. This does not create an attorney-client relationship.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Igniting Long-Term Care Pharmacy | Integra X Files™

Welcome to the inaugural episode of the Integra X Files! Join our hosts Frances Nahas and Jim McDonald in a conversation with guest Chad Worz, Pharm.D., BCGP, FASCP, the chief executive officer of ASCP, as they talk long-term care pharmacy trends, stormtroopers, and highlights from the recent ASCP Annual Meeting.
For all the X-Files Episodes, visit the Integra X-Files
Learn more about your ad choices. Visit megaphone.fm/adchoices

Joseph Washington | Brighter Horizons

Lindsey Childs-Kean, PharmD, MPH, BCPS, co-founder and advisory team member of the #PharmGradWishList interviews Joseph Washington, PharmD/MPH candidate, #PGWL sponsee and winner of the 2021 PGWL Post-Graduate Education Scholarship to support the financial endeavors involved with pursuing graduate pharmacy training.
Joseph is a soon to be graduate of the University of Florida, pursuing a dual degree in pharmacy along with a Master of Public Health, and is fervently paving a way to make his mark in the distinguished profession of clinical sciences. Joseph has a drive to holistically change the landscape of healthcare, to provide equitable access to services amongst all populations. More so, Joseph has had the distinction of serving as the National President for the Student National Pharmaceutical Association, where he routinely amplified the voices of underrepresented minorities. Now, Joseph is looking to begin his career, building off of his clinical prowess, within the realm of health economics and outcomes research.
Joseph is appreciative of the outpouring of support from the pharmacy community, who have devoted efforts to allow young clinicians, such as himself, the opportunity to continue to break down barriers and hurdles.
To support other aspiring pharmacists, like Joseph, please follow @PharmGradWishList on twitter and instagram and check out pharmgradwishlist.org! 
Learn more about your ad choices. Visit megaphone.fm/adchoices

The Entrepreneurial Pharmacist and the Innovation In Pharmacy with George Zorich

For thirty-five years, George S. Zorich worked as a pharmaceutical executive. Along the way, he served on several pharmacy boards, including the ASHP and that of the University of Wisconsin School of Pharmacy. He always found it surprising that graduates were very skilled at clinical pharmacy but not entrepreneurship. His book Entrepreneurs in Pharmacy and Other Leaders will become a useful text for pharmacy students and faculty alike under the new ACPE mandate that pharmacy programs teach entrepreneurship. Section one of the book profiles ten professionals who launched their own innovative businesses from a pharmacy degree. Section two highlights thirty people who became leaders in health care with their pharmacy degrees. Zorich is donating all of the royalties to pharmacy programs and foundations that encourage and foster entrepreneurship.
Learn more about your ad choices. Visit megaphone.fm/adchoices

The Mission of the Senior Care Pharmacy Coalition (SCPC) is about Better Patient Care

According to the Department of Health and Human Services: Fifty-five percent of the elderly are non-compliant with their prescription drug orders, meaning they don't take their medication according to the doctor's instructions. Approximately 200,000 older adults are hospitalized annually due to adverse drug reactions.
Special guest: 
Senior Care Pharmacy Coalition (SCPC) President and CEO Alan Rosenbloom 
Washington, DC – Today, House Committee on Oversight and Reform Ranking Member James Comer (R-Ky.) and minority committee members lawmakers will hold a forum to discuss the impact of pharmacy benefit managers (PBMs) in pharmaceutical markets with industry experts, pharmacists, physicians, and PBMs. In anticipation of the forum the Senior Care Pharmacy Coalition (SCPC) offered the following statement from SCPC President and CEO Alan Rosenbloom:
“We welcome today’s forum to examine PBMs and their anti-competitive practices, which ultimately drive-up costs for patients and put independent pharmacies out of business. A handful of PBMs dominate the market, and most are part of much larger health care conglomerates that spread both horizontally and vertically to encompass prescription drug plans and health insurers, retail, specialty, mail order, and long-term care (LTC) pharmacies, giving them immense power to favor the pharmacies they own over the pharmacies they don’t. This forces some pharmacies, especially LTC pharmacies, to provide life-saving medications to patients at a cost that could put them out of business and threaten patient access to essential medications, particularly in rural and medically underserved communities.
Older Americans with long-term care needs require an average of 12-14 prescriptions per year. They are particularly vulnerable to soaring drug prices, and often least able to adapt when local pharmacies close. This is especially true of Medicare beneficiaries who need long-term care and typically have chronic or medically complex conditions as well. This group requires the medication management and enhanced pharmacy services that LTC pharmacies provide. Any unfair PBM practices that inhibit LTC pharmacy services or force them to close can be life-threatening for the hundreds of thousands of patients they serve daily.
Today is a great first step and we thank Rep. James Comer (R-KY) for holding this important forum. Future inquiries must be bipartisan, and since LTC pharmacies and their patients are uniquely impacted by PBMs, we urge Congress to include LTC pharmacies in policy conversations like this one. Congress must pass legislation that requires transparency in PBM drug pricing and related information and provides stronger oversight to hold PBMs accountable.”
Learn more about your ad choices. Visit megaphone.fm/adchoices

POP CULTURE: Captain America’s Super Soldier Serum | Lets Pharmonize

The contents of the super-soldier serum have been the subject of speculation for decades. Today we learn the truth about what makes Captain America great from our very own Justin Frederick. 
This is NOT your physician's podcast. Hosts Shane Garrettson and Cal Vandergrift dive into the pharmacy world with fun, interesting, and downright weird topics!
Tune in for NEW episodes, available on Spotify, Apple, Anchor, and more! Check out our Facebook, Twitter, and Instagram pages at Let's Pharmonize to view videos and images relevant to every episode! If you have any questions, comments, or even corrections, e-mail us at pharmonization@gmail.com.
PLEASE READ: Shane, Mickey, Cal and Justin are NOT medical professionals. DO NOT USE the information presented in this podcast to aid in your own personal health or medicinal benefit. This is a light-hearted podcast that should not be taken with the same seriousness as your own personal health.
A special thanks to Kelly Kerr for creating the music used in the intro and outro.
Additional Music from Pixabay and Fesliyan Studios
Learn more about your ad choices. Visit megaphone.fm/adchoices